Alex H S Harris1,2, Esther L Meerwijk1, Robin N Kamal3, Erika D Sears4,5, Mary Hawn1,2, Dan Eisenberg1,2, Andrea K Finlay1, Hildi Hagedorn6, Seshadri Mudumbai1,7. 1. From the Center for Innovation to Implementation, Veterans Affairs Palo Alto Healthcare System, Palo Alto, California. 2. Department of Surgery, Stanford-Surgical Policy Improvement Research and Education Center, Stanford University School of Medicine, Stanford, California. 3. Department of Orthopedic Surgery, Stanford University School of Medicine, Stanford, California. 4. Center for Clinical Management Research, Veterans Affairs Ann Arbor Health Care System, Ann Arbor, Michigan. 5. Department of Surgery, Michigan Medicine. 6. Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota. 7. Department of Anesthesiology, Perioperative, and Pain Medicine, Stanford University School of Medicine, Stanford, California.
Abstract
BACKGROUND: The American Society of Anesthesiologists (ASA) Choosing Wisely Top-5 list of activities to avoid includes "Don't obtain baseline laboratory studies in patients without significant systemic disease (ASA I or II) undergoing low-risk surgery - specifically complete blood count, basic or comprehensive metabolic panel, coagulation studies when blood loss (or fluid shifts) is/are expected to be minimal." Accordingly, we define low-value preoperative tests (LVTs) as those performed before minor surgery in patients without significant systemic disease. The objective of the current study was to examine the extent, variability, drivers, and costs of LVTs before carpal tunnel release (CTR) surgeries in the US Veterans Health Administration (VHA). METHODS: Using fiscal year (FY) 2015-2017 data derived from the VHA Corporate Data Warehouse (CDW), we determined the overall national and facility-level rates and associated costs of receiving any of 8 common LVTs in the 30 days before CTR in ASA physical status (PS) I-II patients. We also examined the patient, procedure, and facility factors associated with receiving ≥1 LVT with mixed-effects logistic regression and the number of tests received with mixed-effects negative binomial regression. RESULTS: From FY15-17, 10,000 ASA class I-II patients received a CTR by 699 surgeons in 125 VHA facilities. Overall, 47.0% of patients had a CTR that was preceded by ≥1 LVT, with substantial variability between facilities (range = 0%-100%; interquartile range = 36.3%), representing $339,717 in costs. Older age and female sex were associated with higher odds of receiving ≥1 LVT. Local versus other modes of anesthesia were associated with lower odds of receiving ≥1 LVT. Several facilities experienced large (>25%) increases or decreases from FY15 to FY17 in the proportion of patients receiving ≥1 LVT. CONCLUSIONS: Counter to guidance from the ASA, we found that almost half of CTRs performed on ASA class I-II VHA patients were preceded by ≥1 LVT. Although the total cost of these tests is relatively modest, CTR is just one of many low-risk procedures (eg, trigger finger release, cataract surgery) that may involve similar preoperative testing practices. These results will inform site selection for qualitative investigation of the drivers of low-value testing and the development of interventions to improve preoperative testing practice, especially in locations where rates of LVT are high.
BACKGROUND: The American Society of Anesthesiologists (ASA) Choosing Wisely Top-5 list of activities to avoid includes "Don't obtain baseline laboratory studies in patients without significant systemic disease (ASA I or II) undergoing low-risk surgery - specifically complete blood count, basic or comprehensive metabolic panel, coagulation studies when blood loss (or fluid shifts) is/are expected to be minimal." Accordingly, we define low-value preoperative tests (LVTs) as those performed before minor surgery in patients without significant systemic disease. The objective of the current study was to examine the extent, variability, drivers, and costs of LVTs before carpal tunnel release (CTR) surgeries in the US Veterans Health Administration (VHA). METHODS: Using fiscal year (FY) 2015-2017 data derived from the VHA Corporate Data Warehouse (CDW), we determined the overall national and facility-level rates and associated costs of receiving any of 8 common LVTs in the 30 days before CTR in ASA physical status (PS) I-II patients. We also examined the patient, procedure, and facility factors associated with receiving ≥1 LVT with mixed-effects logistic regression and the number of tests received with mixed-effects negative binomial regression. RESULTS: From FY15-17, 10,000 ASA class I-II patients received a CTR by 699 surgeons in 125 VHA facilities. Overall, 47.0% of patients had a CTR that was preceded by ≥1 LVT, with substantial variability between facilities (range = 0%-100%; interquartile range = 36.3%), representing $339,717 in costs. Older age and female sex were associated with higher odds of receiving ≥1 LVT. Local versus other modes of anesthesia were associated with lower odds of receiving ≥1 LVT. Several facilities experienced large (>25%) increases or decreases from FY15 to FY17 in the proportion of patients receiving ≥1 LVT. CONCLUSIONS: Counter to guidance from the ASA, we found that almost half of CTRs performed on ASA class I-II VHA patients were preceded by ≥1 LVT. Although the total cost of these tests is relatively modest, CTR is just one of many low-risk procedures (eg, trigger finger release, cataract surgery) that may involve similar preoperative testing practices. These results will inform site selection for qualitative investigation of the drivers of low-value testing and the development of interventions to improve preoperative testing practice, especially in locations where rates of LVT are high.
Authors: O D Schein; J Katz; E B Bass; J M Tielsch; L H Lubomski; M A Feldman; B G Petty; E P Steinberg Journal: N Engl J Med Date: 2000-01-20 Impact factor: 91.245
Authors: Aaron L Schwartz; Bruce E Landon; Adam G Elshaug; Michael E Chernew; J Michael McWilliams Journal: JAMA Intern Med Date: 2014-07 Impact factor: 21.873
Authors: John N Mafi; Kyle Russell; Beth A Bortz; Marcos Dachary; William A Hazel; A Mark Fendrick Journal: Health Aff (Millwood) Date: 2017-10-01 Impact factor: 6.301
Authors: Jessica M Welch; Thompson Zhuang; Lauren M Shapiro; Alex H S Harris; Laurence C Baker; Robin N Kamal Journal: Clin Orthop Relat Res Date: 2022-05-24 Impact factor: 4.755
Authors: Alexander J Schupper; William H Shuman; Rebecca B Baron; Sean N Neifert; Emily K Chapman; Jeffrey Gilligan; Jonathan S Gal; John M Caridi Journal: Spine Deform Date: 2020-08-11
Authors: Seshadri C Mudumbai; Suzann Pershing; Tom Bowe; Robin N Kamal; Erika D Sears; Mary T Hawn; Dan Eisenberg; Andrea K Finlay; Hildi Hagedorn; Alex H S Harris Journal: JAMA Netw Open Date: 2021-05-03
Authors: Alex H S Harris; Thomas Bowe; Robin N Kamal; Erika D Sears; Mary Hawn; Dan Eisenberg; Andrea K Finlay; Hildi J Hagedorn; Seshadri Mudumbai Journal: Perioper Med (Lond) Date: 2022-09-13